Dr. David Diemert is Associate Professor in the Departments of Medicine (primary) and Microbiology, Immunology, and Tropical Medicine (secondary) at GW. Additionally, he is the Clinical Director of GW Vaccine Research Unit (GW VRUS), which is a collaboration between the School of Medicine and Health Sciences and GW MFA. At GW, Dr. Diemert is also the co-Director of the Immunology, Hematology, Inflammation and Infection block of the preclinical medical student curriculum. Prior to joining GW, Dr. Diemert worked for four years at the Malaria Vaccine Development Branch of the National Institute of Allergy and Infectious Diseases, where he was responsible for conducting clinical trials of novel malaria vaccines, both in the United States and in Mali, West Africa. Dr. Diemert earned his medical degree from the University of Alberta in Edmonton, Canada, and completed residency and fellowship training at McGill University in Montreal. He is a Fellow of the Royal College of Physicians (Canada) with certification in the specialties of internal medicine, infectious diseases and medical microbiology. Additionally, he received training in clinical tropical medicine through the University of Alabama at Birmingham’s Gorgas Course in Lima, Peru.
Identifying innovative and collaborative solutions throughout the development pathway to advance NTD vaccine candidates beyond historical roadblocks.
2:00 Workshop Leader Opening Remarks
Dr Simona Rondini, Head Bacterial Projects and Senior Project Leader, GSK Vaccines Institute for Global Health
2:20 Panel: Optimizing pre-clinical frameworks to maximize successful transition of NTD vaccines into the critical path
Moderator: Dr Maria Elena Bottazzi, Co-Director of Texas Children’s Hospital for Vaccine Development, Baylor College of Medicine
Dr Phillip Felgner, Director, UCI Vaccine Research & Development Center & Protein Microarray Laboratory and Training Facility, University of California IrvineDr Simona Rondini, Head Bacterial Projects and Senior Project Leader, GSK Vaccines Institute for Global Health
Dr Jeffrey Bethony, Professor & Vice Chair for Translational Research, Department of Microbiology, Immunology & Tropical Medicine, The George Washington University
Dr Jay Evans, Chief Scientific and Strategy Officer, Inimmune & Director of the Center for Translational Medicine at the University of Montana
3:20 Panel: Navigating the Critical Path: Advancing NTD Vaccines Beyond Phase II
Moderator: Dr Orin Levine, Non-Resident Fellow, Center for Global Development
Dr David Diemert, Professor & Clinical Director, GW Vaccine Research Unit, The George Washington University
Amy Finan, CEO, Sabin Vaccine Institute
Dr Milagritos Tapia, Professor of Pediatrics, University of Maryland
4:15 Transnational & Regional Approaches to Pandemic PreparednessDr Jerome Kim, Director General, IVI
Prof Leo Poon, Chair of Public Health Virology, The University of Hong Kong
Dr Gaurav Pandey, Head of Vaccine Process Development, IVI